Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | Zendy

Mark G. Thompson | Zendy; Jefferey L. Burgess | Zendy; Allison L. Naleway | Zendy; Harmony L. Tyner | Zendy; Sarang K. Yoon | Zendy; Jennifer K. Meece | Zendy; Lauren E.W. Olsho | Zendy; Alberto J. Cabán-Martinez | Zendy; Ashley Fowlkes | Zendy; Karen Lutrick | Zendy; Holly C. Groom | Zendy; Kayan Dunnigan | Zendy; Marilyn J. Odean | Zendy; Kurt T. Hegmann | Zendy; Elisha Stefanski | Zendy; Laura Edwards | Zendy; Natasha Schaefer Solle | Zendy; Lauren Grant | Zendy; Katherine Ellingson | Zendy; Jennifer L. Kuntz | Zendy; Tnelda Zunie | Zendy; Matthew S. Thiese | Zendy; Lynn Ivacic | Zendy; Meredith G. Wesley | Zendy; Julie Mayo Lamberte | Zendy; Xiaoxiao Sun | Zendy; Michael Smith | Zendy; Andrew L. Phillips | Zendy; Kimberly Groover | Zendy; Young M. Yoo | Zendy; Joseph Gerald | Zendy; Rachel T. Brown | Zendy; Meghan K. Herring | Zendy; Gregory Joseph | Zendy; Shawn C. Beitel | Zendy; Tyler Morrill | Zendy; Josephine Mak | Zendy; Patrick Rivers | Zendy; Brandon Poe | Zendy; Brian Lynch | Zendy; Yingtao Zhou | Zendy; Jing Zhang | Zendy; Anna Kelleher | Zendy; Yan Li | Zendy; Monica Dickerson | Zendy; E. W. Hanson | Zendy; Kyley Guenther | Zendy; Suxiang Tong | Zendy; Allen C. Bateman | Zendy; Erik Reisdorf | Zendy; John Barnes | Zendy; Eduardo AzzizBaumgartner | Zendy; Danielle Rentz Hunt | Zendy; Melissa Arvay | Zendy; Preeta K. Kutty | Zendy; Alicia M. Fry | Zendy; Manjusha Gaglani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Author(s) -

Mark G. Thompson,

Jefferey L. Burgess,

Allison L. Naleway,

Harmony L. Tyner,

Sarang K. Yoon,

Jennifer K. Meece,

Lauren E.W. Olsho,

Alberto J. Cabán-Martinez,

Ashley Fowlkes,

Karen Lutrick,

Holly C. Groom,

Kayan Dunnigan,

Marilyn J. Odean,

Kurt T. Hegmann,

Elisha Stefanski,

Laura Edwards,

Natasha Schaefer Solle,

Lauren Grant,

Katherine Ellingson,

Jennifer L. Kuntz,

Tnelda Zunie,

Matthew S. Thiese,

Lynn Ivacic,

Meredith G. Wesley,

Julie Mayo Lamberte,

Xiaoxiao Sun,

Michael Smith,

Andrew L. Phillips,

Kimberly Groover,

Young M. Yoo,

Joseph Gerald,

Rachel T. Brown,

Meghan K. Herring,

Gregory Joseph,

Shawn C. Beitel,

Tyler Morrill,

Josephine Mak,

Patrick Rivers,

Brandon Poe,

Brian Lynch,

Yingtao Zhou,

Jing Zhang,

Anna Kelleher,

Yan Li,

Monica Dickerson,

E. W. Hanson,

Kyley Guenther,

Suxiang Tong,

Allen C. Bateman,

Erik Reisdorf,

John Barnes,

Eduardo AzzizBaumgartner,

Danielle Rentz Hunt,

Melissa Arvay,

Preeta K. Kutty,

Alicia M. Fry,

Manjusha Gaglani

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2107058

Subject(s) - covid-19 , messenger rna , coronavirus , virology , medicine , severe acute respiratory syndrome coronavirus , disease , infectious disease (medical specialty) , biology , outbreak , gene , biochemistry

Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research